Medtronic has expanded its investment in Asia with the launch of its first robotics experience studio in the region. The state-of-the-art facility, included in an expansion of the Medtronic Customer eXperience Center (MCXC) in Singapore, aims to accelerate the adoption of robotics and AI across Southeast Asia through training and education, improving access to new healthcare technologies and delivering better care experiences.
Since the opening of MCXC in November 2022, Medtronic says it has made substantial strides in medical education and upskilling, training more than 2,000 healthcare professionals across Asia and conducted nearly 1,400 training and experience sessions. The addition of the Robotics Experience Studio will amplify these efforts by providing cutting-edge resources for healthcare professionals to hone their skills in robotic-assisted procedures and AI applications.
“The Robotics Experience Studio will enable Medtronic to work closely with local stakeholders, including healthcare providers, academia, industry forums and government to further bring new technologies closer to Asia for better patient outcomes,” said Medtronic’s Majid Kaddoumi.
Medical technology advances in robotics and AI have demonstrated significant improvements in patient outcomes, which include reduced complications, faster recovery times and improved precision in surgical interventions. However, despite significant economic growth in some parts of Asia, the provision of equitable and accessible healthcare is still an ongoing challenge in the region.
“Medtronic’s latest investment underscores Singapore’s role as a leading hub for healthcare innovation and talent in Asia Pacific,” said Jacqueline Poh, Managing Director at Singapore’s Economic Development Board. “The Robotics Experience Studio builds on Medtronic’s manufacturing and regional headquarters activities in Singapore to position for the evolving needs of its customers in the areas of robotics and AI for healthcare.”
